Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers

Clinical Interventions in Aging

Volumn 2, Issue 4, 2007, Pages 509-519

  Edwards, Paul C ^a   Fantasia, John E ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Foreign body reaction; Granuloma; Hyaluronic acid; Hylaform ; Injectable dermal filler; Restylane

Indexed keywords

CORTICOSTEROID; HYALURONIC ACID;

ADVERSE OUTCOME; BIOCHEMISTRY; CHEMICAL STRUCTURE; DEGRADATION; DELAYED HYPERSENSITIVITY; FOREIGN BODY GRANULOMA; FOREIGN BODY REACTION; HISTOLOGY; HUMAN; IMMUNOGENICITY; INFECTION; INJECTABLE IMPLANT; INJECTION SITE CONTUSION; INJECTION SITE REACTION; NONHUMAN; PAIN; PATHOGENESIS; PLASTIC SURGERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SWELLING; SYNTHESIS; VISUAL DISORDER; ANIMAL; CHEMISTRY; CUTANEOUS PARAMETERS; DRUG CONTRAINDICATION; DRUG DESIGN; DRUG EFFECT; ESTHETIC SURGERY; UNITED STATES;

ANIMALS; COSMETIC TECHNIQUES; DRUG DESIGN; FOREIGN-BODY REACTION; HUMANS; HYALURONIC ACID; SKIN AGING; UNITED STATES;

EID: 39749117622     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s382     Document Type: Review

References (49)

1. Alessandrini A, Di Bartolo C, Pavesio A, et al. 2006. ACP gel: a new hyaluronic acid-based injectable for facial rejuvination. Preclinical data in a rabbit model. Plast Reconstr Surg, 118:341–6.
2. Andre P. 2004. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA- Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol, 18:422–5.
3. Andre P, Lowe NJ, Parc A, et al. 2005. Adverse reactions to dermal fillers: a review of European experiences. J Cosmetic Laser Surg, 7:171–6.
4. Bennet R, Taher M. 2005. Restylane persistent for 23 months found during Mohs micrographic surgery: a source of confusion with hyaluronic acid surrounding basal cell carcinoma. Dermatol Surg, 31:1366–9.
5. Carruthers J, Carruthers A. 2003. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg, 29:802–9.
6. Coleman SR. 2005. Cross-linked hyaluronic acid fillers. Plastic Reconstr Surg, 117:661–5.
7. Dal Sacco D, Cozzani E, Parodi A, et al. 2005. Scar sarcoidosis after hyaluronic acid injection. Int J Dermatol, 44:411–12.
8. Desai AM, Browning J, Rosen T. 2006. Etanercept therapy for silicone granuloma. J Drugs Dermatol, 5:894–6.
9. Edwards PC, Fantasia JE, Iovino R. 2006. Foreign body reaction to hyaluronic acid (Restylane): an adverse outcome of lip augmentation. J Oral Maxillofac Surg, 64:1296–9.
10. Fernandez-Acenero MJ, Zamora E, et al. 2003. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg, 29:1225–6.
11. Fernandez-Cossio S, Castano-Oreja MT. 2006. Biocompatibility of two novel dermal fillers: histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler. Plast Reconstr Surg, 117:1789–96.
12. Friedman PM, Mafong EA, Kauvar AN, et al. 2002. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg, 28:491–4.
13. Ghersetich I, Lotti T, Campanile G, et al. 1994. Hyaluronic acid in cutaneous intrinsic aging. Int J Dermatol, 33:119–22.
14. Ghislanzoni M, Bianchi F, Barbareschi M, et al. 2006. Cutaneous granulomatous reaction to injectable hyaluronic acid gel. Brit J Dermatol, 154:755–8.
15. Glaich AS, Cohen JL, Goldberg LH. 2006. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg, 32:276–81.
16. Hamra ST. 2006. $25,000 and still counting. Plastic Reconstructive Surg, 118:801–3.
17. Hill A, McFarlane S, Johnston PG, et al. 2006. The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Letts, 237:1–9.
18. Hirsch RJ, Lupo M, Cohen JL, et al. 2007. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase. J Drugs Dermatol, 6:325–8.
19. Honig JF, Brink U, Korabiowska M. 2003. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. J Craniofac Surg, 14:197–200.
20. Jordan JR. 2005. Delayed inflammatory reaction to hyaluronic acid (Restylane). Ophthal Plast Reconstr Surg, 21:401–2.
21. Klein AW. 2005. Re: hypersensitivity reactions to injectable hyaluronic acid: reality or fiction. Dermatol Surg, 31:1745.
22. Lemperle G, Morhenn V, Charrier U. 2003. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg, 27:354–66.
23. Leonhardt JM, Lawrence N, Narins RS. 2005. Angioedema acute hypersensitivity reaction to injectable hyaluronic acid. Dermatol Surg, 31:577–9.
24. Lombardi T, Samson J, Plantier F, et al. 2004. Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med, 33:115–20.
25. Lowe NJ. 2003. Re: arterial embolization caused by injection of hyaluronic acid (Restylane). Brit J Dermatol, 148:379–80.
26. Lowe NJ, Maxwell CA, Lowe PL, et al. 2001. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol, 45:930–3.
27. Lowe NJ, Maxwell CA, Patnaik R. 2005. Adverse reactions to dermal fillers: review. Dermatol Surg, 31:1616–25.
28. Lupton JR, Alster TS. 2000. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg, 26:135–7.
29. Matarasso SL, Carruthers JD, Jewell ML, et al. 2006. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plastic Reconstructive Surg, 117:s3–34.
30. Matarasso SL, Herwick R. 2006. Hypersensitivity reaction to nonanimal stabilized hyaluronic acid. J Am Acad Dermatol, 55:128–31.
31. Micheels P. 2001. Human anti-hyaluronic acid antibodies: is it possible? Dermatol Surg, 27:185–91.
32. Narins RS, Brandt F, Leyden J, et al. 2003. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg, 29:588–95.
33. Parada MB, Michalany NS, Hassun KM, et al. 2005. A histologic study of adverse effects of different cosmetic skin fillers. Skinmed, 4:345–9.
34. Patel VJ, Bruck MC, Katz BE. 2006. Hypersensitivity reaction to hyaluronic acid with negative skin testing. Plast Reconstr Surg, 117:e92–4.
35. Peter S, Mennel S. 2006. Retinal branch artery occlusion following injection of hyaluronic acid (Restylane). Clin Experiment Ophthalmol, 34:363–4.
36. Raulin C, Greve B, Hartschuh W, et al. 2000. Exudative granulomatous reaction to hyaluronic acid (Hylaform). Contact Dermatitis, 43:178–9.
37. Richter AW, Ryde EM, Zetterstrom EO. 1979. Nonimmunogenicity of a purified sodium hyaluronate preparation in man. Int Arch Allergy Appl Immunol, 59:45–8.
38. Rongioletti F, Cattarini G, Sottofattori E, et al. 2003. Granulomatous reaction after intradermal injections of hyaluronic acid gel. Arch Dermatol, 139:815–16.
39. Sasaki M, Miyazaki Y, Takahashi T. 2003. Hylan G-F 20 induces delayed foreign body inflammation in guinea pigs and rabbits. Toxicol Pathol, 31:321–5.
40. Schanz S, Schippert W, Ulmer A, et al. 2002. Arterial embolization caused by injection of hyaluronic acid (Restylane). Brit J Dermatol, 146:920–32.
41. Shafir R, Amir A, Gur E. 2000. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconst Surg, 106:121–6.
42. Soparkar CN, Patrinely JR. 2005. Managing inflammatory reaction to Restylane. Ophthalmic Plastic Reconstr Surg, 21:151–64.
43. Soparkar CN, Patrinely JR, Tschen J. 2004. Erasing Restylane. Ophthal Plast Reconstr Surg, 20:317–18.
44. Stern R. 2003. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology, 13:r105–15.
45. Termeer C, Sleeman JP, Simon JC. 2003. Hyaluronan-magic glue for the regulation of the immune response? Trends Immunology, 24:112–14.
46. Toy BR, Frank PJ. 2003. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg, 29:971–3.
47. Vargas-Machuca I, Gonzalez-Guerra E, Angulo J, et al. 2006. Facial granulomas secondary to Dermalive microimplants: report of a case with histopathologic differential diagnosis among the granlomas secondary to different injectable permanent filler materials. Am J Dermatopathol, 28:173–7.
48. Walker RF. 2006. On the evolution of anti-aging medicine. Clinical Interventions in Aging, 1:201–3.
49. Wolfram D, Tzankov A, Piza-Katzer H. 2006. Surgery for foreign body reactions due to injectable fillers. Dermatology, 213:300–4.